The Endocrine Society is pleased to announce the five early career endocrinologists who have received the 2024 Early Investigator Awards. The Early Investigators Awards were established to help develop early career investigators and recognize their accomplishments in endocrine-related research. Recipients will receive a $1,000 monetary award, complimentary registration and the opportunity to present at ENDO, one-year...
Endocrine Society Celebrates Special Diabetes Program Extension
The Endocrine Society applauds Congress for approving the first funding increase for the Special Diabetes Program in two decades. The U.S. Senate voted Friday March 8 to extend the program, which supports both diabetes care and research into type 1 diabetes, until the end of 2024. This is part of the six-bill package funding several...
Carol Lange, PhD, Elected 2025-2026 Endocrine Society President
Endocrine Society members elected Carol Lange, PhD, of the University of Minnesota in Minneapolis, Minn., as its 2025-2026 president. She will serve as president-elect for a year beginning in June 2024 before becoming President in June 2025. A professor of medicine and molecular pharmacology and therapeutics, Lange also holds the Tickle Family Land Grant Endowed...Endocrine Society Supports Federal Legislation Protecting IVF Access
The Endocrine Society is calling for members of Congress to support federal legislation protecting access to in vitro fertilization (IVF). The Access to Family Building Act (S.3612/H.R.7056), proposed by Sens. Tammy Duckworth (D-IL), Patty Murray (D-WA), and Rep. Susan Wild (D-PA), would ensure people can access safe, effective IVF and other assisted reproductive technologies to...
New Position Statement Focuses on Patient Experience in Diabetes Care
Healthcare providers who treat diabetes need to think beyond the clinical numbers, such as solely focusing on a person’s glucose goals. Taking the patient experience into account can improve the quality of care and facilitate attainment of treatment goals, according to a new position statement published in the Endocrine Society’s Journal of Clinical Endocrinology &...
Introducing EndoForum, the Endocrine Society’s Rebranded Online Community
After initially launching in 2022 and growing into a thriving community in 2023, the Endocrine Society’s online community in DocMatter is ready to step out into the spotlight with a brand-new name: EndoForum! Why change the name? EndoForum is more than just the platform it’s on; it is a vibrant and active community of more than 16,000 Endocrine Society...
Endocrine Society Applauds Ohio Governor Veto of State Ban on Gender-affirming Care for Minors
The Endocrine Society applauds Governor Mike Dewine’s veto of a proposed Ohio law that would have banned gender-affirming care for minors. The bill he vetoed contradicts mainstream medical practice and scientific evidence and would have taken medical decision-making out of the hands of families and their physicians and instead relied upon government officials. More than...
Fact Check: Endocrine Society Responds to Republican Debate Misinformation
The statement Florida Gov. Ron DeSantis made during Wednesday’s Republican presidential debate contradicts mainstream medical practice and scientific evidence. DeSantis’ comments characterizing gender-affirming care for transgender and gender-diverse youth as child abuse and genital mutilation do not reflect the healthcare landscape. Contrary to widespread misinformation, gender-affirming genital surgery is rarely offered to anyone under the...
